Rep. Kevin Hern sold Colgate-Palmolive Company (CL)
Rep. Kevin Hern (R-OK-1) · $1K–$15K · traded Aug 19, 2026
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Aug 19, 2026
- Disclosed
- Sep 1, 2026
- Days to disclose
- 13
- Asset type
- Stock
- As filed
- Colgate-Palmolive Company Common Stock
- Industry
- Household & Personal Products · Consumer Defensive
Other trades in this filing
All of Hern's trades →- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
Traded 8 days before earnings - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$50K–$100K
Sold The Procter & Gamble Company PG
$50K–$100K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$100K–$250K
Bought CANADIAN CNTY OKLA EDL FACS AUTH EDL 3.00000% 09/01/2029
$100K–$250K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
Sold Marsh & McLennan Companies MRSH
$1K–$15K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$50K–$100K
Sold (partial) The Home Depot HD
$50K–$100K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
Got $20K from the company’s PAC - Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 21, 2026 · disclosed Sep 1, 2026 · Joint
Got $11K from the company’s PAC - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 21, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
Got $5K from the company’s PAC - Sep 1, 2026$1K–$15K
Sold Anheuser-Busch InBev SA/NV BUD
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
Sold (partial) ICON Public Limited Company ICLR
$15K–$50K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
Got $19K from the company’s PAC - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
Got $19K from the company’s PAC - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
Recent Congress trades in CL
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 2, 2026 · disclosed Sep 25, 2026 · Joint
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 31, 2026 · disclosed Sep 25, 2026
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 25, 2026
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Bought Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
Company context for CL
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
CL: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
CL: Financial results
Filed 8-K for an event or period dated 2026-10-30. Financial results.
CL: third_quarter 2026 lobbying report
FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products
Public: Oct 17, 2026, 8:49 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.